Evidence map›Paper›PMID 32610141›Full record

ArticleCell reports2020

Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone.

Pengrong Yan, Hardik J Patel, Sahil Sharma, Adriana Corben, Tai Wang, Palak Panchal, Chenghua Yang, Weilin Sun, Thais L Araujo, Anna Rodina and 16 more

Abstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. ATM interaction with GRP94 modulates oncogenic receptor expression and signaling and microglial activation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Mapping Dysfunctional Protein-Protein Interactions in Disease.Journal of visualized experiments : JoVE · 2025
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. CCDC134 controls TLR biogenesis through the ER chaperone Gp96.The Journal of experimental medicine · 2025
    Article
  15. Article
  16. Review
  17. Epichaperome-targeted myocardial imaging byClinical and translational imaging · 2024
    Article
  18. Review
  19. Extrinsic and Cell-Intrinsic Stress in the Immune Tumor Micro-Environment.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Pengrong YanChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Hardik J PatelChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sahil SharmaChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Adriana CorbenDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Currently at Mount Sinai Hospital, New York, NY 10029, USA.
Tai WangChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Palak PanchalChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Chenghua YangChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Currently at Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Weilin SunChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Thais L AraujoChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Anna RodinaChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Suhasini JoshiChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Kenneth RobzykChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Srinivasa GanduChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Julie R WhiteComparative Pathology Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Elisa de StanchinaMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Shanu ModiDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Yelena Y JanjigianDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Elizabeth G HillHollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
Bei LiuPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH 43210, USA.
Hediye Erdjument-BromageDepartment of Cell Biology and Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Thomas A NeubertDepartment of Cell Biology and Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Nanette L S QueHauptman-Woodward Medical Research Institute, Buffalo, NY 14203, USA.
Zihai LiPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH 43210, USA.
Daniel T GewirthHauptman-Woodward Medical Research Institute, Buffalo, NY 14203, USA.
Tony TaldoneChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Gabriela ChiosisChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: chiosisg@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Translating Stress Response Targeted Therapy for B-Cell LymphomasP50CA192937 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI DALLA-FAVERA, RICCARDO, ZELENETZ, ANDREW D. · 2016 to 2020
$10.9M
Targeting Epigenetic Circuits in B-Cell LymphomasR35CA220499 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MELNICK, ARI M. · 2018 to 2024
$7.2M
Project 3: Structural Basis for grp94 Drug Development and Chaperone FunctionP01CA186866 · NCI · OHIO STATE UNIVERSITY · PI GEWIRTH, DANIEL T · 2015 to 2019
$6.7M
Molecular chaperones and immune toleranceR01AI077283 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2009 to 2021
$3.7M
Small molecule Hsp90 inhibitors in AD treatmentU01AG032969 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2010 to 2014
$3.5M
Biomarkers for predicting response to Hsp90 therapyR01CA172546 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA, DUNPHY, MARK P. · 2013 to 2017
$2.9M
Targeting the heat shock response for the therapy of DLBCLR01CA155226 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHIOSIS, GABRIELA, MELNICK, ARI M. · 2011 to 2015
$2.5M
A chemical chaperomics platform for ADR56AG061869 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2018 to 2019
$1.8M
Integration of inflammation and cancer by molecular chaperoneR01CA213290 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2017 to 2021
$860k
Design, synthesis and evaluation of selective Grp94 inhibitorsR21AI090501 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2010 to 2011
$460k
NCI NIH HHS P01 CA186866NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA192937NCI NIH HHS R01 CA155226NCI NIH HHS R01 CA172546NCI NIH HHS R01 CA213290NCI NIH HHS R35 CA220499NIAID NIH HHS R01 AI077283NIAID NIH HHS R21 AI090501NIA NIH HHS R56 AG061869NIA NIH HHS U01 AG032969
6 · The paper itself

Abstract

Stresses associated with disease may pathologically remodel the proteome by both increasing interaction strength and altering interaction partners, resulting in proteome-wide connectivity dysfunctions. Chaperones play an important role in these alterations, but how these changes are executed remains largely unknown. Our study unveils a specific N-glycosylation pattern used by a chaperone, Glucose-regulated protein 94 (GRP94), to alter its conformational fitness and stabilize a state most permissive for stable interactions with proteins at the plasma membrane. This "protein assembly mutation' remodels protein networks and properties of the cell. We show in cells, human specimens, and mouse xenografts that proteome connectivity is restorable by inhibition of the N-glycosylated GRP94 variant. In summary, we provide biochemical evidence for stressor-induced chaperone-mediated protein mis-assemblies and demonstrate how these alterations are actionable in disease.

Indexed as

AnimalsCell Line, TumorCytosolGlycosylationHSP70 Heat-Shock ProteinsHumansMembrane ProteinsMice, Inbred NODMolecular ChaperonesMolecular WeightNeoplasmsOncogenesPolysaccharidesProtein Conformationglucose-regulated proteinsHSP70 Heat-Shock ProteinsMembrane ProteinsMolecular ChaperonesPolysaccharidesaberrant N-glycosylationaberrant protein-protein interactioncellular stresschaperome-mediated protein connectivity dysfunctionepichaperomeGRP94protein mis-assemblystable protein assemblystress-mediated molecular dysfunctiontargeted protein degradation-based therapeutics

Identifiers

PMID32610141
PMCPMC7372946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.